Taiwan FDA registration f32b94099834ec238cf78e868aa7f378
BD Phonenix EMERGE AST Indicator
TW: BD藥物敏感性試驗指示劑
Taiwan·Risk Class 2·MD·BECTON DICKINSON AND COMPANY·Registered Jun 17, 2022 – Jun 17, 2027ActiveRegistration details
- Analysis ID
- f32b94099834ec238cf78e868aa7f378
- License Form
- Ministry of Health Medical Device Import No. 035658
- Customs Code
- DHA05603565802
Company information
- Manufacturer
- BECTON DICKINSON AND COMPANY
- Manufacturer Country
- United States
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
Product details
- Intended Use
- This product utilizes color changes resulting from bacterial growth as a principle for bacterial growth detection in BD Phoenix automated microbial systems.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C1620 Antimicrobial susceptibility test tray
- Import Information
- Imported from abroad; GMP
Dates and status
- Registration Date
- Jun 17, 2022
- Expiry Date
- Jun 17, 2027
About this record
Access comprehensive regulatory information for BD Phonenix EMERGE AST Indicator in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f32b94099834ec238cf78e868aa7f378 and manufactured by BECTON DICKINSON AND COMPANY. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices